The insider cluster is routine and not actionable. Focus on the ASR announcement: the $477.6M buyback (2.2% of market cap) signals management's confidence and will reduce share count. Monitor final settlement in Q4 2026 for additional share retirements.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 10 $503.86entry
- T+1 · 2mo ago −1.34%α −2.19% · $497.11
- T+5 · 2mo ago −1.31%α −1.94% · $497.27
- T+20 · 6w ago +5.74%α +3.62% · $532.78
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Martine Rothblatt sold ~$6.4M in open-market shares on the same day United Therapeutics announced a $477.6M accelerated share repurchase agreement (ASR). The sales represent only 0.03% of the $21.4B market cap and are consistent with routine option exercise and tax withholding. The ASR is a material positive, but the insider cluster itself is trivial in size and not predictive.
Key Financial Metrics
Key Facts
- CEO Rothblatt sold ~$6.4M in open-market shares on Sep 4 and Sep 8, 2026, while also exercising options.
- EVP & General Counsel Mahon sold $97K on Sep 3.
- Total open-market sales of ~$6.5M equal 0.03% of UTHR's $21.4B market cap.
- On Sep 8, UTHR announced a $477.6M ASR with Citibank to repurchase shares under its existing buyback program.
- The CEO's sales are likely tied to option exercises (strike $117.76) and tax obligations, not a bearish signal.
Financial Impact
Insider sales of $6.5M are negligible relative to $21.4B market cap. The ASR repurchase of $477.6M is the dominant capital allocation event.
Risk Factors
- CEO selling alongside a buyback announcement could raise governance questions, but the dollar amount is immaterial.
- If the ASR underperforms (stock drops during the averaging period), the buyback may be less accretive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1789027341189 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers